Every record from Kestrel · page 3
Fast and inexpensive, on a 15-minute gradient that co-elutes mass-identical diastereomers. Results read high. Measured offset against the reference laboratory is +0.382 pp on 296 paired lots. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042104 | Retatrutide | TFC | TFC-2512-G7985 | 2026-Q2 | 99.49 | 1.97 | 95.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042266 | Liraglutide | Homopeptide | HOMO-2602-E2761 | 2026-Q2 | 99.93 | 4.32 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041842 | Tirzepatide | JEEP | JEEP-2602-J2798 | 2026-Q2 | 98.85 | 4.67 | 106.4 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042557 | GHK-Cu | ERP | ERP-2601-F7633 | 2026-Q2 | 98.86 | 4.43 | 95.4 | Supplier-supplied | 0 | PASS |
| AX-2026-041755 | Selank | FGP | FGP-2511-D1094 | 2026-Q1 | 99.93 | 5.91 | 92.8 | Supplier-supplied | 0 | PASS |
| AX-2026-041343 | CJC-1295 with DAC | WWB | WWB-2508-V3100 | 2026-Q1 | 99.93 | 5.79 | 106.0 | Supplier-supplied | 1 | FAIL |
| AX-2026-041519 | Retatrutide | QYB | QYB-2602-R6263 | 2026-Q2 | 99.34 | 6.33 | 93.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042772 | BPC-157 | GGPeps | GGPE-2602-N9882 | 2026-Q2 | 99.57 | 5.19 | 98.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041672 | Ipamorelin | QSC | QSC-2602-W8804 | 2026-Q1 | 99.93 | 6.75 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042996 | TB-500 | KP | KP-2605-C4659 | 2026-Q2 | 99.93 | 5.82 | 98.9 | Supplier-supplied | 0 | PASS |
| AX-2026-043311 | L-Glutathione (reduced) | CPC | CPC-2602-D2535 | 2026-Q1 | 98.58 | 7.71 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042608 | Semax | GGPeps | GGPE-2511-X8435 | 2026-Q1 | 98.47 | 7.88 | 90.7 | Supplier-supplied | 1 | FAIL |
| AX-2026-041475 | AOD-9604 | QYB | QYB-2508-E6017 | 2026-Q1 | 99.93 | 3.65 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042926 | Semaglutide | MKM | MKM-2508-R2718 | 2026-Q1 | 99.41 | 5.66 | 100.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043554 | MK-677 (Ibutamoren mesylate) | BCH | BCH-2601-G7069 | 2026-Q1 | 98.39 | 4.06 | 90.4 | Supplier-supplied | 2 | FAIL |
| AX-2026-041468 | Thymosin α1 | QYB | QYB-2511-V6148 | 2026-Q1 | 99.44 | 2.86 | 101.7 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042414 | Semaglutide | SWB | SWB-2602-W5529 | 2026-Q1 | 99.33 | 5.88 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042142 | Leuprolide | Homopeptide | HOMO-2508-N8842 | 2026-Q1 | 99.93 | 6.01 | 94.0 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042496 | Melanotan II | SWB | SWB-2602-J6019 | 2026-Q1 | 99.93 | 4.47 | 92.0 | Supplier-supplied | 0 | PASS |
| AX-2026-042143 | Leuprolide | Homopeptide | HOMO-2508-N8842 | 2026-Q1 | 99.82 | 5.08 | 93.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041470 | Humanin (HNG) | QYB | QYB-2512-A5720 | 2026-Q1 | 99.14 | 5.04 | 93.4 | Supplier-supplied | 2 | FAIL |
| AX-2026-041418 | GHRP-2 | WWB | WWB-2511-K4194 | 2026-Q1 | 99.93 | 4.82 | 92.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042131 | Semax | Homopeptide | HOMO-2602-S8315 | 2026-Q1 | 99.93 | 9.49 | 101.5 | Supplier-supplied | 3 | MARGINAL |
| AX-2026-042732 | Tirzepatide | GGPeps | GGPE-2510-L9923 | 2026-Q1 | 99.08 | 3.65 | — | Supplier-supplied | 3 | MARGINAL |
| AX-2026-043439 | Melanotan II | WXT | WXT-2511-P5160 | 2026-Q1 | 99.93 | 4.76 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041992 | Semaglutide | TFC | TFC-2508-A5297 | 2026-Q1 | 99.93 | 4.14 | — | Supplier-supplied | 2 | FAIL |
| AX-2026-042078 | BPC-157 | TFC | TFC-2512-L7022 | 2026-Q1 | 98.86 | 5.48 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042681 | Retatrutide | GGPeps | GGPE-2510-R9180 | 2026-Q1 | 99.85 | 2.79 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041964 | KPV | TFC | TFC-2508-M4888 | 2026-Q1 | 99.36 | 2.86 | 89.2 | Supplier-supplied | 1 | FAIL |
| AX-2026-041560 | TB-500 | QYB | QYB-2511-H6699 | 2026-Q1 | 99.38 | 5.92 | 106.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041971 | KPV | TFC | TFC-2508-M4888 | 2026-Q1 | 99.93 | 3.76 | — | Supplier-supplied | 0 | FAIL |
| AX-2026-042111 | MK-677 (Ibutamoren mesylate) | TFC | TFC-2601-L7836 | 2026-Q1 | 99.93 | 6.38 | — | Supplier-supplied | 1 | FAIL |
| AX-2026-041242 | Retatrutide | WWB | WWB-2510-H1662 | 2026-Q1 | 98.68 | 4.76 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043584 | MOTS-c | BCH | BCH-2601-S7929 | 2026-Q1 | 98.50 | 6.49 | 88.7 | Supplier-supplied | 2 | FAIL |
| AX-2026-042527 | PEG-MGF | ERP | ERP-2509-K6500 | 2026-Q1 | 97.92 | 4.96 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042887 | CJC-1295 with DAC | MKM | MKM-2602-M1973 | 2026-Q1 | 99.93 | 3.83 | 91.4 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041687 | Semaglutide | QSC | QSC-2508-F9226 | 2026-Q1 | 99.93 | 5.35 | 103.6 | Supplier-supplied | 2 | FAIL |
| AX-2026-042049 | Tirzepatide | TFC | TFC-2508-L6746 | 2026-Q1 | 98.96 | 1.76 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041702 | Survodutide | QSC | QSC-2509-E9456 | 2026-Q1 | 99.67 | 6.18 | 99.1 | Laboratory-retained | 2 | MARGINAL |
| AX-2026-043542 | Ipamorelin | BCH | BCH-2510-P7043 | 2026-Q1 | 99.20 | 3.08 | — | Supplier-supplied | 2 | MARGINAL |